• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌的预后因素:一项多变量分析

Prognostic factors of renal cell carcinoma: a multivariate analysis.

作者信息

Yasunaga Y, Shin M, Miki T, Okuyama A, Aozasa K

机构信息

Department of Pathology, Osaka University Medical School, Suita, Japan.

出版信息

J Surg Oncol. 1998 May;68(1):11-8. doi: 10.1002/(sici)1096-9098(199805)68:1<11::aid-jso4>3.0.co;2-o.

DOI:10.1002/(sici)1096-9098(199805)68:1<11::aid-jso4>3.0.co;2-o
PMID:9610657
Abstract

BACKGROUND AND OBJECTIVES

To establish appropriate therapeutic modalities for renal cell carcinoma (RCC), informations on the factors affecting prognosis of patients are essential. For this purpose, multivariate analysis including a large set of variables is necessary.

METHODS

Prognostic significance of 14 clinical factors and 19 histologic factors including counting of silver-stained nucleolar organizer regions (AgNORs) were evaluated in 96 patients. Age of patients ranged from 41 to 85 (median 59) yr with a male to female ratio of 4:1. The tumors were staged based on the TNM classification as follows: 7 in stage I, 58 in stage II, 15 in stage III, and 11 in stage IV.

RESULTS

The overall and metastasis-free survival rates in all patients were 80.1% and 72.7%, respectively. Multivariate analysis using Cox's proportional hazards model performed on the factors proved to be significant at the univariate analysis. Univariate analysis revealed four clinical factors including presence of macroscopic hematuria, symptoms such as pain and palpable abdominal mass, anemia, and adjuvant therapy, and nine histologic factors, including AgNOR count, to be significant for survival. Multivariate analysis showed that anemia, pathological stage, and AgNOR count were independent factors for overall survival of patients. The AgNOR count, in particular, is the only predictive factor for metastasis-free survival.

CONCLUSIONS

Among various clinicopathological factors, anemia, pathological stage, and AgNOR count are significant prognosticators of RCC. The AgNOR count is also predictive factor for metastasis-free survival.

摘要

背景与目的

为了建立肾细胞癌(RCC)的合适治疗方式,了解影响患者预后的因素至关重要。为此,需要进行包含大量变量的多因素分析。

方法

对96例患者评估了14项临床因素和19项组织学因素(包括银染核仁组织区计数(AgNORs))的预后意义。患者年龄在41至85岁之间(中位年龄59岁),男女比例为4:1。肿瘤根据TNM分类分期如下:I期7例,II期58例,III期15例,IV期11例。

结果

所有患者的总生存率和无转移生存率分别为80.1%和72.7%。对单因素分析中被证明具有显著性的因素采用Cox比例风险模型进行多因素分析。单因素分析显示,包括肉眼血尿、疼痛和可触及腹部肿块等症状、贫血及辅助治疗在内的4项临床因素,以及包括AgNOR计数在内的9项组织学因素对生存有显著性意义。多因素分析表明,贫血、病理分期和AgNOR计数是患者总生存的独立因素。特别是AgNOR计数,是无转移生存的唯一预测因素。

结论

在各种临床病理因素中,贫血、病理分期和AgNOR计数是肾细胞癌的重要预后指标。AgNOR计数也是无转移生存的预测因素。

相似文献

1
Prognostic factors of renal cell carcinoma: a multivariate analysis.肾细胞癌的预后因素:一项多变量分析
J Surg Oncol. 1998 May;68(1):11-8. doi: 10.1002/(sici)1096-9098(199805)68:1<11::aid-jso4>3.0.co;2-o.
2
A prognostic significance of nucleolar organizer region (AgNOR) in renal cell carcinoma.核仁组成区(AgNOR)在肾细胞癌中的预后意义。
J Urol. 1995 Oct;154(4):1522-6.
3
Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.乳头状肾细胞癌的形态学分型:66例生长动力学及患者生存情况比较
Hum Pathol. 2001 Jun;32(6):590-5. doi: 10.1053/hupa.2001.24984.
4
Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.嗜银核仁组成区在肿瘤检测及预后中的作用
Cancer Detect Prev. 1995;19(3):282-91.
5
Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.乳头状(嗜色性)肾细胞癌:62例的组织形态学特征及传统病理预后参数评估
Am J Surg Pathol. 1997 Jun;21(6):621-35. doi: 10.1097/00000478-199706000-00001.
6
Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.通过抗固定多克隆Ki-67抗体标记评估肾细胞癌的增殖。与临床结果的相关性。
Cancer. 1995 Jun 1;75(11):2714-9. doi: 10.1002/1097-0142(19950601)75:11<2714::aid-cncr2820751113>3.0.co;2-x.
7
Nucleolar organizer regions and prognosis in renal cell carcinoma.肾细胞癌中的核仁组织区与预后
J Pathol. 1991 Jan;163(1):31-7. doi: 10.1002/path.1711630107.
8
Argyrophilic nucleolar organizer region counts predict survival in thymoma.嗜银核仁组织区计数可预测胸腺瘤的生存率。
Cancer. 1994 Sep 1;74(5):1568-74. doi: 10.1002/1097-0142(19940901)74:5<1568::aid-cncr2820740512>3.0.co;2-r.
9
High and low risk prostate carcinoma determined by histologic grade and proliferative activity.根据组织学分级和增殖活性确定的高风险和低风险前列腺癌
Cancer. 1997 May 15;79(10):1956-63. doi: 10.1002/(sici)1097-0142(19970515)79:10<1956::aid-cncr17>3.0.co;2-u.
10
Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.非小细胞肺癌中p53免疫反应性、核仁组织区及增殖细胞核抗原的评估
Anticancer Res. 2000 Jan-Feb;20(1B):505-10.

引用本文的文献

1
The complement system and kidney cancer: pathogenesis to clinical applications.补体系统与肾癌:从发病机制到临床应用
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188351.
2
AgNOR patterns and configurations in adult acute leukemia patients.成人急性白血病患者的核仁组成区嗜银蛋白(AgNOR)模式与形态
Cent Eur J Immunol. 2022;47(4):323-331. doi: 10.5114/ceji.2022.124252. Epub 2023 Jan 31.
3
Analysis of Argyrophilic Nucleolar Organizer Regions (AgNORs) in Acute Leukemia in Adults.成人急性白血病中嗜银核仁组成区(AgNORs)的分析
Diagnostics (Basel). 2022 Mar 28;12(4):832. doi: 10.3390/diagnostics12040832.
4
The Prognostic Factors for Patients with pT1a Renal Cell Carcinoma.pT1a期肾细胞癌患者的预后因素
Korean J Urol. 2010 Apr;51(4):233-8. doi: 10.4111/kju.2010.51.4.233. Epub 2010 Apr 20.
5
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.肾细胞癌中通过AKT磷酸化实现p27的细胞质隔离
Clin Cancer Res. 2009 Jan 1;15(1):81-90. doi: 10.1158/1078-0432.CCR-08-0170.
6
VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value.肾细胞癌亚型中血管内皮生长因子(VEGF)、环氧合酶-2(COX-2)和增殖细胞核抗原(PCNA)的表达及其预后价值。
Int Urol Nephrol. 2008;40(4):861-8. doi: 10.1007/s11255-008-9362-7. Epub 2008 Mar 7.
7
Cyclooxygenase-2 expression: does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?环氧化酶-2表达:它在肾细胞癌的肿瘤发生机制中是否具有潜在作用?
Int Urol Nephrol. 2008;40(2):295-301. doi: 10.1007/s11255-007-9268-9.
8
Classical pathology versus molecular pathology in renal cell carcinoma.肾细胞癌中的经典病理学与分子病理学
Curr Urol Rep. 2007 Jan;8(1):5-11. doi: 10.1007/s11934-007-0015-7.
9
Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.环氧化酶-2和p53表达作为传统肾细胞癌的预后指标
Yonsei Med J. 2005 Feb 28;46(1):133-40. doi: 10.3349/ymj.2005.46.1.133.